Oncology & Systemic Delivery
Targeted nanoparticulate systems for cancer and enhanced systemic bioavailability of critical nutrients.
Targeted solid lipid nanoparticles (SLNs) loaded with docetaxel for breast cancer treatment, showing highly promising tumor reduction in preclinical studies — designed as a theranostic platform combining therapy and diagnostic tracking.
Vitamin A and D3 bioavailability is significantly enhanced via SLN technology (Indian and US patent granted), improving oral and subcutaneous absorption of these critical nutrients with implications for deficiency-related conditions globally.
Buccal delivery of nicotine with enhanced stability and controlled release rounds out the systemic delivery portfolio, offering a cleaner pathway for smoking cessation pharmacotherapy.
Patents
- 355216 — Solid nanolipidic particulates of vitamin D3 and retinoic acid (India, granted 2021)
- US 9907758 B2 — Solid lipid sustained release nanoparticles for vitamins (USA, granted 2018)
- 299469 — Solid lipid nanoparticles for improving bioavailability of rifampicin (India, granted 2018)
- 425821 — Process for encapsulating macrobiomolecules in solid lipid nanoparticles (India, granted 2023)
- 349184 — In situ forming lipidic nanoparticles (India, granted 2020)
- 202011047599 — Simultaneous detection and treatment tool for cancers (India, filed 2020)